ELDNEledon Pharmaceuticals, Inc.
3.450USD-2.82%Mkt Cap: 280.35M $P/E: —3d ago
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and preve…